Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StarwormsWP1: Validation of Diagnostic Tools for STH
NCT03465488Completed
- Sponsor
- Ghent University
- Start
- Aug 2016
- Primary completion
- Jan 2018
- Countries
- 4
01
Overview
Open-label, single-arm trial, sponsored by Ghent University. Primary endpoints: Validation of the performance of FECPAKG2 to assess drug efficacy at 12 months and Validation of b-tubulin gene as a molecular marker for benzimidazole resistance at 24 months. Started Aug 2016; status: completed.
Beyond the preview
Go deeper on NCT03465488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03465488.